has anyone gotten cancer from semaglutide GLP-1 medications may offer benefits beyond weight loss and diabetes management, including improved outcomes for breast patients who are obese or have type 2 diabetes, according to new research. The study ⚠️ OZEMPIC NOW LINKED TO

Combined with research showing weight loss to improve menstruation, fertility (3), and insulin resistance (4), ways to help weight loss in women with polycystic ovary syndrome are being sought

This supports the hypothesis that ciliopathies, such as BBS, involve intrinsic defects in leptin and insulin pathways that are exacerbated, rather than solely caused, by obesity

Doing this can result in negative issues with your health

Yet, its rarely talked about

was supported by grants by ANII (ART_X_2023_1_175670, ART_X_2021_1_170221, IDI_X_2023_1_179312 and HPI_X_2024_1_181183), CSIC (22620220100034UD), PEDECIBA and FOCEM (COF 03/11)

In the analysis that most closely reflects real-world clinical practice, participants taking oral semaglutide lost an average of 13.6% of their starting body weight, compared with just 2.4% in those receiving placebo